Medicinal Plants as a Potential and Successful Treatment Option in the Context of Atherosclerosis

Tatiana V Kirichenko1,2,3, Vasily N Sukhorukov1,2,3, Alexander M Markin1

  • 1Laboratory of Infection Pathology and Molecular Microecology, Research Institute of Human Morphology, Moscow, Russia.

Insights

Medicinal plants show promise in combating atherosclerosis, a leading cause of death. Their compounds offer safe, multi-action therapies for cardiovascular disease prevention and treatment.

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Phytotherapy

Background:

  • Atherosclerosis is a major cause of mortality in developed nations, driven by lipid profile changes and vascular inflammation.
  • Cardiovascular diseases stemming from atherosclerosis necessitate effective prevention and therapeutic strategies.
  • Medicinal plants offer a potential avenue for managing atherosclerosis due to their diverse biological activities.

Purpose of the Study:

  • To review and synthesize current research on the anti-atherosclerotic properties of medicinal plants.
  • To investigate the experimental and clinical evidence supporting the use of medicinal plants against atherosclerosis.
  • To assess the safety and efficacy of plant-derived compounds in managing atherosclerosis.

Main Methods:

  • Systematic literature search of PubMed and Scopus databases up to November 2019.
  • Analysis of experimental studies investigating anti-atherosclerotic mechanisms of medicinal plants.
  • Review of clinical trials assessing the impact of medicinal plants on atherosclerosis progression, such as carotid intima-media thickness (IMT).

Main Results:

  • Medicinal plants exhibit pleiotropic anti-atherosclerotic effects, including anti-inflammatory, antioxidant, lipid-lowering, and anti-thrombotic actions.
  • Plant-derived compounds demonstrate relative safety and fewer side effects compared to conventional therapies.
  • Clinical studies have confirmed the direct anti-atherosclerotic effects of certain medicinal plants on carotid IMT progression.

Conclusions:

  • Medicinal plants represent a promising source of novel anti-atherosclerotic agents.
  • The multi-target action and favorable safety profile of plant compounds support their consideration in atherosclerosis management.
  • Further research and clinical validation are warranted to fully harness the therapeutic potential of medicinal plants for cardiovascular health.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
263
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
275
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
179
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
178
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
367
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
186